inforMED
InjuryLMF

SURGIFLO¿ HEMOSTATIC MATRIX KIT WITH THROMBIN

Received Jun 1, 2026 · Event occurred Nov 11, 2025

Report 3008478369-2026-00020 · MDR key 25345989

Add to watch list
Product code (LMF)
Manufacturer (Ferrosan Medical Devices A/s)
Model (2994)

Device

Generic name

Agent, Absorbable Hemostatic, Collagen Based

Model number

2994

Product problems

  • Off-Label Use

Patient

NA · Unknown

  • Post Operative Wound Infection

Narrative

Additional Manufacturer Narrative

NO LOT NUMBER IS AVAILABLE.

Description of Event or Problem

CASE 1 OF 3: IT WAS REPORTED THAT GYN SURGEON USES SURGIFLO ON THE VAGINAL CUFF. HE HAS HAD 3 SSIS SINCE CONVERTING FROM FLOSEAL TO SURGIFLO IN OCTOBER. HE THINKS SURGIFLO MIGHT BE GIVING HIS PATIENT'S SSIS. NO SURGICAL DELAY WAS REPORTED. PROCEDURE: (B)(6) 2025, EVENT: 11/03/2025 PROCEDURE: GYN. ADDITIONAL INFORMATION WAS RECEIVED ON 28.05.2026 STATING: WHAT IS THE NAME OF EACH PROCEDURE? ALL 3 REPORTS WERE FROM TOTAL HYSTERECTOMIES WHAT WAS THE DATE OF EACH PROCEDURE? PATIENT 1: (B)(6) 2025 PATIENT 2: 1(B)(6) 2025 PATIENT 3: (B)(6) 2025. ON WHAT DATE DID EACH INFECTION OCCUR? PATIENT 1: (B)(6) 2025 PATIENT 2: (B)(6) 2025 PATIENT 3: (B)(6) 2025. HOW MUCH SURGIFLO WAS USED DURING EACH PROCEDURE? ONE UNIT OF 2994 WAS USED PER PATIENT/CASE WAS SURGIFLO REMOVED AFTER HEMOSTASIS WAS ACHIEVED? SURGIFLO WAS NOT REMOVED AFTER HEMOSTASIS ON ANY OF THE 3 PATIENTS. WHAT WAS THE INDICATION FOR THE USE OF SURGIFLO? HEMOSTASIS AFTER THE VAGINAL CUFF WAS CLOSED. WHAT WAS THE INDICATION FOR SURGERY? REMOVAL OF THE UTERUS AND CERVIX FOR ALL 3 PATIENTS. WHAT WAS THE MEDICAL HISTORY OF EACH PATIENT? PATIENT 1: UTERINE FIBROIDS PATIENT 2: ENDOMETRIOSIS PATIENT 3: ADENOMYOSIS. WHAT WAS THE TREATMENT FOR EACH SURGICAL SITE INFECTION? OPEN AND DRAIN THE WOUND, REMOVE SUTURES, IRRIGATION AND DEBRIDEMENT, ANTIBIOTICS FOR ALL 3 PATIENTS WHAT ARE THE LOT NUMBERS? I WAS NOT GIVEN THE LOT NUMBERS AS IT WAS REPORTED AFTER THE SURGICAL DATES. CAN SPECIFIC PATIENT DEMOGRAPHICS INITIALS / ID; AGE OR DATE OF BIRTH; BMI; PATIENT PRE-EXISTING MEDICAL CONDITIONS (I.E. ALLERGIES, HISTORY OF REACTIONS), ALL CONCOMITANT MEDICATIONS, PAST MEDICAL HISTORY, ANY TREATMENT REQUIRED FOR EVENTS, DOSE, FREQUENCY, AND THERAPY DATES OF STUDY DRUGS BE PROVIDED? I ASKED FOR THIS INFORMATION, AND THE SURGEON WOULD NOT PROVIDE IT. WHAT IS THE SURGEON'S OPINION REGARDING THE RELATIONSHIP BETWEEN THE PRODUCT AND THE SYMPTOMS? THE SURGEON BELIEVES THE ONLY PROTOCOL THAT WAS CHANGED WAS MOVING FROM FLOSEAL TO SURGIFLO DURING THE 3 SSIS. WHAT IS THE CURRENT CONDITION OF EACH PATIENT? ALL 3 PATIENTS HAVE RECOVERED FROM THEIR SSIS AND ARE HEALTHY IN THAT REGARD.